Search

Your search keyword '"Mukohara T"' showing total 183 results

Search Constraints

Start Over You searched for: Author "Mukohara T" Remove constraint Author: "Mukohara T"
183 results on '"Mukohara T"'

Search Results

1. PI3K mutations in breast cancer: prognostic and therapeutic implications

2. 264P Increased membrane HER3 expression in brain metastases compared to primary tumors in breast cancer

3. 534P A pilot study of neoadjuvant olaparib for patients with HRD-positive advanced ovarian cancer

4. 256P Difference of immunological status and response to immune checkpoint inhibitor between recurrent and de novo stage IV HER2-negative breast cancer in NEWBEAT trial (WJOG9917BTR)

5. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

9. LBA4 Datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate (ADC), for triple-negative breast cancer (TNBC): Preliminary results from an ongoing phase I trial

13. 346P Phase I study of the liposomal formulation of eribulin (E7389-LF): Results from the HER2-negative breast cancer expansion

14. 583P Effect of infusion rate, premedication, and prophylactic peg-filgrastim treatment on the safety of the liposomal formulation of eribulin (E7389-LF): Results from the expansion part of a phase I study

15. Abstract OT1-12-02: Biomarker study of patients with HER2-negative metastatic breast cancer receiving combination therapy with nivolumab, bevacizumab and paclitaxel as first-line treatment (WJOG9917BTR)

22. Pathophysiological Role of Cachexia in Patients with Advanced Pancreatic Cancer

24. Dacarbazine Mono-Therapy for Unresectable Neuroendocrine Tumor: A Retrospective Analysis

34. Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

41. Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.

42. Japanese experience with second-line chemotherapy with low-dose (60 mg/M2) docetaxel in patients with advanced non-small-cell lung cancer.

46. Cutaneous endometrial cancer arising from heterotopic endometriosis in an abdominal caesarean section scar.

50. 58P Safety and pharmacokinetics (PK) of vepdegestrant in Japanese patients with estrogen receptor (ER)+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer: Results from a Japanese phase I study.

Catalog

Books, media, physical & digital resources